BioSpace News Archive

BioEclipse Therapeutic™ announced today that Pamela Reilly Contag , Ph.D., Founder and CEO, will present at the H.C. Wainwright Annual Global Healthcare Conference taking place virtually Sept 13-15, 2021.

AcelRx Pharmaceuticals, Inc. today announced that management will be providing an overview of the business and company updates at the H.C. Wainwright & Co. 23rd Annual Global Investment Conference taking place September 13-15, 2021, and at the Cantor Fitzgerald Virtual Global Healthcare Conference taking place September 27-30, 2021.

Iveric Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present virtually at the BofA Securities

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted seven new employees restricted stock units to acquire 94,750 shares of the company’s common stock.

Mirum Pharmaceuticals, Inc. announced that on September 10, 2021, the Compensation Committee of Mirum’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 87,500 shares of common stock to ten new employees under Mirum’s 2020 Inducement Plan.

Soft tissue injuries are frequent among a substantial chunk of the populace and are one of the most common musculoskeletal disorders.

The growing biopharmaceutical research and development activities, technological advancements in SUB, and growing biologics market are some of the key factors responsible for the growth in the single-use bioreactor market.

Medivir AB announces that the company will present at the virtual meeting H.C. Wainwright Annual Global Investment Conference, September 13-15.

United Therapeutics Corporation (Nasdaq: UTHR) today announced the release of its second annual Corporate Responsibility Report with 2020 highlights